|
HS Code |
235755 |
| Chemical Name | Nicotine Bitartrate |
| Molecular Formula | C10H14N2·C4H6O6 |
| Molecular Weight | 340.36 g/mol |
| Appearance | White to off-white crystalline powder |
| Solubility | Soluble in water |
| Cas Number | 54-11-5 (nicotine), 6019-11-6 (bitartrate salt) |
| Storage Conditions | Store at room temperature, keep container tightly closed |
| Pharmacological Class | Cholinergic agonist |
| Uses | Smoking cessation aid, research chemical |
| Melting Point | 92-95°C |
| Ph In Solution | 4.0-5.0 (1% solution) |
| Synonyms | Nicotine hydrogen tartrate, Nicotine ditartrate |
As an accredited Nicotine Bitartrate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Nicotine Bitartrate, 100g packed in a sealed, amber glass bottle with tamper-evident cap, labeled with hazard and safety information. |
| Shipping | Nicotine Bitartrate is shipped in tightly sealed, chemical-resistant containers under cool, dry conditions. Packaging complies with hazardous material regulations, using adequate labeling for poison and environmental hazards. Transport is arranged according to local and international safety standards to prevent spills, exposure, or contamination during transit. Suitable for professional, authorized recipients only. |
| Storage | Nicotine Bitartrate should be stored in a tightly sealed container, protected from light and moisture, in a cool, dry, and well-ventilated area. Ideally, storage temperatures should be between 15-30°C. It should be kept away from incompatible substances and out of reach of unauthorized personnel. Proper labeling and adherence to regulatory guidelines for hazardous chemicals are essential. |
Applications of Nicotine Bitartrate in Industrial ManufacturingAs a direct manufacturer, we supply nicotine bitartrate for highly controlled sectors where strict regulatory compliance and precise formulation are required. Below, we outline key industry segments that implement nicotine bitartrate as an active ingredient or additive, providing process-critical integration details, compliance frameworks, and technical application insights specific to each downstream use. 1. Pharmaceutical Nicotine Replacement Therapy (NRT) FormulationsPharmaceutical producers employ nicotine bitartrate as an active pharmaceutical ingredient (API) within regulated NRT products, including sublingual tablets and oral lozenges designed for controlled nicotine release. Given the necessity to maintain consistent drug potency and release kinetics, formulation chemists select the bitartrate salt for its reliable solubility and compatibility with direct compression and wet granulation processes. Manufacturing must align with regional pharmacopeial specifications and validated GMP environments to meet global medicinal product requirements. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Clinical Research and Reference Standard SupplyControlled clinical research and pharmaceutical quality control laboratories rely on high-purity nicotine bitartrate as calibration standards and blinded controls. This application segment requires exacting purity documentation and traceable batch analysis, typically for use in pharmacokinetics, bioequivalence trials, or new dosage form validations. Researchers require stability and solubility under predefined laboratory protocols, with material entry managed through analytical grade supply chains and detailed Certificates of Analysis. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Veterinary Parasite Control FormulationsNicotine bitartrate finds legacy application in veterinary manufacturing, particularly in ectoparasiticide formulations used by niche animal health providers. Producers use its rapid bioavailability for targeted external application products. Stringent residue and safety controls apply, and ingredient traceability must correspond with veterinary product registration and adverse event monitoring requirements in end-market geographies. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Tobacco Science Reference and Analytical ApplicationsStandardized nicotine bitartrate serves as a reference compound for tobacco leaf assay calibration, cigarette yield analysis, and inhalation measurement studies performed by accredited laboratories and regulatory authorities. The high analytical purity and salt form compatibility with aqueous extraction protocols enable laboratories to establish precise quantitative benchmarks. Documentation packages emphasize traceability and match multi-jurisdictional lab compliance schemes. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Nicotine Delivery Device Manufacturing (Inhalers, Patch Reservoirs)Manufacturers of regulated nicotine delivery devices apply the bitartrate salt for its defined solubility in aqueous carriers and controlled transdermal or pulmonary release profiles. Engineering and production teams integrate the ingredient during the formulation of device reservoirs or refill cartridges. QC procedures verify uniformity and long-term stability, with continual oversight to comply with medical device and combination product filings in respective jurisdictions. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Nicotine Bitartrate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
At our facility, we dive into nicotine chemistry every day. Nicotine bitartrate stands out as one of the more practical forms of nicotine salts. We make it at scale for customers who require consistent, controlled performance—something only real chemical producers can guarantee. Decades of experience in alkaloid extraction taught us how finicky nicotine can be, from sensitive raw leaf sourcing to the volatility of purified freebase. Converting this alkaloid to a stable salt takes more than mixing and watching crystals form. Small temperature fluctuations, impurities in auxiliary acids, and inconsistent mixing speed all lead to wild swings in final product quality. We have learned that only tight process control—combined with in-line monitoring—keeps each batch of nicotine bitartrate within strict assay and purity targets. No guesswork, no shortcuts.
Over the years, many buyers have asked for nicotine salts because of their renowned stability and safer handling compared to freebase nicotine. Nicotine bitartrate, in particular, has historically proven itself in regulated pharmaceutical formulations as well as specialized research applications. Our product delivers a white to off-white crystalline powder with a typical nicotine content above 98%, paired with low water and solvent residues. It stores well in dry conditions and resists the unwanted yellowing or degradation common with loose nicotine bases.
Buyers working on smoking cessation, oral delivery projects, and pharmaceutical developments come back to bitartrate time after time. Our internal data shows the bitartrate salt remains stable for well over 24 months under proper storage, offering better shelf life and less risk of active ingredient loss over time. Most product recalls in the past several years, in the pharmaceutical nicotine segment, came from formulations using unstable freebase derivatives. Switching to bitartrate reduced these incidents, something our technical staff observed as far back as the mid-2010s when patch and gum producers revised their supplier standards.
Nothing guides a manufacturer’s hand like real-world feedback. Early on, we learned to adjust particle size distribution based on blending needs in tablet or patch manufacturing. We mill and sieve to strict controls: 90% of our nicotine bitartrate reaches customers with narrow particle size tolerances. No unexpected lumps, no heavy dusting. That’s a big deal on automated lines. Moisture content never exceeds 0.5%, and we keep heavy metals and solvent residues far below pharmacopeia limits. Every batch comes with in-house chromatographic and titrimetric results, not just a printout from a supplier’s overseas aggregator.
Having produced both D-tartrate and S-tartrate salts, we understand why the bitartrate wins out: improved solubility, fewer off-tastes, and better batch-to-batch repeatability. Unlike less common salts like nicotine sulfate or benzoate, bitartrate doesn’t create pH swings or require exotic excipients in formulation trials. One customer in the 2019 European tablet market reported close to 15% better release characteristics in their pilot runs when switching from commercial nicotine sulfate to our bitartrate grade. Not all salts are interchangeable, and formulation chemists know that a seemingly small change ripples through entire production workflows. We’ve seen savings in production stops, fewer complaints about caking, and better finished product color and taste profiles with our process.
Counterfeit ingredients and impure salts have been a thorn in the side of the nicotine supply chain. Our team sets aside samples from every lot, storing them for years in both ambient and accelerated conditions. Monitoring for stability in actual customer packaging—not just in our stockroom—lets us see how real transit and storage affect quality. After multiple high-profile ingredient scandals in the past decade, most of our customers now demand authentication and traceability for every batch. Full documentation and transparent lab processes grew out of these demands, not as a marketing afterthought.
We see growing interest in smaller batch sizes, especially as newer nicotine products head toward more targeted clinical trials and specialized therapy approaches. Scaling production down, oddly, requires just as much care as industrial-scale batches. Minor process errors show up more clearly in 1–10 kg runs, where analytical uncertainty can eat up a bigger slice of a batch. Our laboratories use the same reference standards and validated methodologies on clinical and developmental grades as on our 500 kg lots. Feedback from contract developers—some aiming for injectable prototypes, others for slow-release oral films—helped us modify our filtration systems and improve our analytical turnaround time. We find that every customer, no matter the size, expects the same reliability and responsiveness from us as their supplier.
A manufacturer can’t stay in business long without knowing every corner of compliance. Years of documented inspections from international regulatory agencies taught us the value of in-house expertise. Many regulatory failures across the global nicotine market come from relying on secondary suppliers or poorly documented intermediates. We took these lessons seriously, investing in on-site analytical teams, chain-of-custody procedures, and data retention that holds up to scrutiny years down the line. For clinical and pharmaceutical use, our nicotine bitartrate batches come with comprehensive impurity profiles and stability results—no recycled or speculative paperwork. Audit after audit, we have learned that transparency and consistent testing do more for a customer’s peace of mind than any marketing claim.
Staff working on the floor and in the labs gain a sense of pride from seeing their work leave the loading dock, destined for life-changing products. New employees train alongside veterans with two decades in the field, learning that every temperature spike during crystallization, every day the packaging film sits in improper humidity, makes a difference to the final integrity of the product. No technician gets to sign off on a batch until it passes in-lab and externally validated testing, and everyone knows their attention to detail matters down the line. This deep personal accountability spills over into creative problem-solving and collaboration with our customers. When a customer finds a new application—say, an oral patch format with unique moisture requirements—our team jumps into trials and troubleshooting, treating every project as a hands-on challenge. We shape our process around practical outcomes, not around what’s most convenient for us.
No manufacturing process stays the same year over year. Our laboratory teams routinely pull in suggestions from outside users—clinical teams, R&D programs, and even end-users in regulated consumer products. In the past 10 years, customers’ push for lower nitrosamine levels pushed us to modify several purification steps, even before regulatory limits came into focus. Our technical teams keep records of every performance tweak, tracking the impact of enhanced filtration stages on product appearance and purity. This reservoir of hands-on knowledge helps us respond quickly when clients ask for tighter spec ranges or specialized ingredient profiles.
We commit significant resources to analytical chemistry, not just as a compliance tool but as a performance differentiator. In practice, this means routine use of GC-MS, HPLC, and trace metals screening, backed up with regular proficiency testing. Only by running these checks can we support claims about low residual solvents, accurate assay, and purity above industry norms. We encourage customers to reference our data against their own in-house laboratories—any inconsistency is treated as a challenge to improve rather than a customer service headache. Unlike sellers who source nicotine salts from unpredictable partners, we benefit by holding the entire process—from raw input to final packaging—under one set of eyes.
Sourcing tobacco sustainably is now as important to many customers as the purity of the finished salt. We have responded by building traceability into our raw material supply chain. Local audits, regular soil testing, and supplier engagement meetings help maintain confidence that the leaves processed into pure nicotine don’t originate from exploited labor or risky agricultural practices. Waste streams from nicotine extraction are monitored for safety, neutralized on-site, and reported via environmental disclosures. Upgrades to solvent recovery and waste minimization dropped our total annual chemical outflows by over 25% in the past five years, directly reflecting a commitment our staff, neighbors, and customers see as non-negotiable.
People ask how to spot the difference between a real manufacturer and a repackager. Our answer: visit the plant, see the process, talk to the chemists and operators whose names match the batch records. We have invested in both the talent and infrastructure—reactors, quality controls, real engineering staff—to turn out consistent, reliable nicotine bitartrate every time. During the pandemic, when logistics froze and counterfeiters flooded the market, we maintained consistent output and responsiveness, thanks to robust internal stocks, staff cross-training, and a network of trusted partners. Customers call on us directly when an urgent batch release threatens a clinical trial or interrupts a manufacturing line. Only the true manufacturer carries this level of flexibility.
Manufacturing does not end at the loading dock. We support customers from first sampling to post-delivery troubleshooting. Over the years, we have seen most batch issues traced back not to product failures but to environmental swings on the customer site, unexpected interaction with excipients, or mismatches in material handling. With staff available for technical consultation and rapid replacement, our customers have cut downtime and avoided costly project setbacks. Collaboration breeds more resilient supply chains.
As a manufacturer, we keep one eye on today’s demands and another on emerging regulatory requirements. Legislative changes, from nitrosamine guidelines in the EU to US FDA traceability mandates, often release well before official enforcement. By keeping our processes documented and fully auditable, we keep our customers competitive and minimize regulatory surprises. Our product data management system, regularly reviewed for data integrity, lets customers respond efficiently to audits or information requests. Anticipating what’s next, we join industry associations and regulatory working groups, giving us early warning of upcoming trends and requirements.
The technology backing nicotine bitartrate manufacturing has evolved. In-line NIR, automated microfiltration, and accelerated stability chambers raise performance and reliability to ever higher standards. Still, experience born of setbacks—contaminated batches, hard-to-clean reactors, seasonal changes in input quality—counts as much as hardware improvements. Having made this salt for years, we know every stage where things can go wrong and how to respond when they do. The difference comes through in the reliability of delivered product, the support behind the batch, and the drive to adapt processes as science and market needs move forward.
Manufacturing nicotine bitartrate draws on every lesson learned from process intricacies, real-world applications, and supply chain realities. From careful material sourcing to every phase of validation, we do not simply make a product—we create a backbone others rely upon. The science, the regulatory care, and the human attention all serve a single purpose: ensure that every batch of nicotine bitartrate we ship meets more than a set of numbers on a certificate. With each shipment, we stand by the expertise, transparency, and responsibility earned over years of dedicated work in nicotine chemistry.